Tectonic Therapeutic reported $227.07M in Cash and Equivalent for its fiscal quarter ending in June of 2026.





Cash And Equivalent Change Date
Akebia Therapeutics USD 159.25M 3.71M Sep/2026
Alnylam Pharmaceuticals USD 1.75B 46.02M Sep/2026
Celltrion KRW 51.7B 5.1B Jun/2026
Cspc Pharmaceutical CNY 6.09B 1.48B Dec/2025
Deva Holding AS TRY 775.92M 574.67M Sep/2023
Dianthus Therapeutics USD 55.69M 54.86M Sep/2026
Divis Laboratories Ltd INR 1.28B 2.87B Mar/2026
Gilead Sciences USD 3.18B 4.45B Jun/2026
Ionis Pharmaceuticals USD 296.3M 53.76M Sep/2026
Kangmei Pharma CNY 1.23B 48.16M Mar/2026
Karyopharm Therapeutics USD 90.85M 30.31M Mar/2026
Knight Therapeutics CAD 76.45M 5.43M Dec/2025
Laboratorios Farma EUR 46.11M 18.92M Jun/2025
MacroGenics USD 49.03M 64.88M Sep/2026
Malin Corporation EUR 62.1M 26.4M Dec/2024
Medical Developments International AUD 17.84M 219K Jun/2025
Neuren Pharmaceuticals AUD 4.23M 1.68M Dec/2025
Organigram Holdings CAD 10.85M 6.56M Jun/2026
Pfizer USD 1.82B 848M Sep/2026
Pharma Mar EUR 19.34M 29.53M Jun/2026
Qiagen NV USD 768.5M 122.21M Jun/2026
Roche Holding CHF 7.55B 579M Jun/2025
Sangamo BioSciences USD 38.34M 13.16M Jun/2025
Sanofi EUR 6.35B 806M Jun/2026
Sarepta Therapeutics USD 472.76M 98.39M Sep/2026
Sartorius EUR 230.7M 60.3M Sep/2026
Sino Biopharmaceutical CNY 3.38B 2.09B Dec/2024
Takeda JPY 418.53B 42.45B Sep/2026
Tilray USD 264.83M 43.16M Jun/2025
Zealand Pharma A/S 3.85B 727.54M Mar/2026
Zz Pientze Pharmaceu CNY 2.11B 157.33M Jun/2026